Keywords: نوش; Fibrosis; NASH; Adipocytokine; Cholesterol; Fructose;
مقالات ISI نوش (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: نوش; ACC; acetyl CoA carboxylase; ALT; alanine aminotransferase; AMPK; 5' adenosine monophosphate-activated protein kinase; AST; aspartate transaminase; CRP; C-reactive protein; FAS; fatty acid synthase; HFD; high-fat diet; HMB; β-hydroxy-β-methyl-butyrate
Keywords: نوش; Liver Cancer; NASH; Incidence; Time; AFP; α-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; CPT; Common Procedural Terminology; EMR; electronic medical records; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepati
Keywords: نوش; Noninvasive; Steatosis; Biomarker; Response to Treatment; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BMI; body mass index; MRI; magnetic resonance imaging; MRS; magnetic resonance spectroscopy; NAFLD; nonalcoholic fatty liver disease;
Keywords: نوش; VAT; visceral adipose tissue; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; VO2peak; peak oxygen consumption; LO:HI; low to moderate intensity, high volume aerobic exercise; HI:LO; high intensity, low volume aerobic exerci
Keywords: نوش; ALT; alanine aminotransferase; BMI; body mass index; FFQ; food-frequency questionnaire; HOMA; homeostasis model assessment; HRI; hepatorenal index; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; US; ultrasonography;
Keywords: نوش; AIF; apoptosis-inducing factor; BSO; Buthionine sulfoximine; CAM; chorioallantoic membrane; cIAP; cellular inhibitor of apoptosis; DR5; death receptor-5; ENDOG; endonuclease G; ER; endoplasmatic reticulum; FCS; fetal calf serum; HBV; hepatitis B virus; HC
Keywords: نوش; Glucocorticoids; Cortisol; NAFLD; NASH; Glucocorticoid Receptor; Adipose tissue
Keywords: نوش; Dysbiosis; Leaky Gut; Alcoholic Liver Disease; NASH; NAFLD; Cirrhosis; Microbiome; PAMPsALD, alcoholic liver disease; AMP, antimicrobial peptides and proteins; Fiaf, fasting-induced adipocyte factor; HFD, high-fat diet; IBD, inflammatory bowel disease; IL
Keywords: نوش; Genetic Factors; Fatty Liver; NASH; NAFLD; AE; additive genetic and unique environment model; ALT; alanine aminotransferase; CI; confidence interval; DZ; dizygotic; MRE; magnetic resonance elastography; MRI; magnetic resonance imaging; MZ; monozygotic; NA
Keywords: نوش; 4-HNE; 4-hydroxynonenal; ALT; alanine-aminotransferase; Arg-1; arginase 1; iNOS; inducible nitric oxide synthase; IR; insulin receptor; IRS-1; insulin receptor substrate 1; MCP-1; monocyte chemotactic protein 1; MyD88; myeloid differentiation primary resp
Keywords: نوش; APL; Acquired partial lipodystrophy; CGL; Congenital generalized lipodystrophy; MPGN; Membranoproliferative glomerulonephritis; FPL; Familial partial lipodystrophy; TuLip; Turkish Lipodystrophy Study Group; WB MRI; Whole body magnetic resonance imaging; N
Keywords: نوش; ALT; alanine transaminase; AST; aspartate transaminase; BMI; body mass index; CLD; congenital leptin deficiency; Cmax; peak serum concentration; CYP450; cytochrome P450; DXA; dual-energy X-ray absorptiometry; FGF21; fibroblast growth factor 21; FSH; folli
Keywords: نوش; CT scanning; Holocene; Mediterranean; Speleothem; Palaeoclimatology; NASH;
Keywords: نوش; NAFLD; non-alcoholic fatty liver disease; FA; fatty acids; FFA; free fatty acids; TFA; total FFA; mtDNA; mitochondrial deoxyribonucleic acid; RT-PCR; real-time polymerase chain reaction; ANOVA; analysis of covariance; HOMA-IR; homeostatic model assessment
Keywords: نوش; NAFLD; NASH; Lipotoxicity; Free cholesterol; Cholesterol homeostasis; Liver;
Keywords: نوش; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BMI; body mass index; EGD; esophagoduodenoscopy; FXR; farnesoid X receptor; HCC; hepatocellular carcinoma; LDL; low-density lipoprotein; MRE; magnetic resonance elastography; NAFL; nonalcohol
Keywords: نوش; GLP-1; glucagon-like peptide 1; 25OHD; 25-hydroxyvitamin D; RDA; recommended daily allowance; IGF-1; insulin-like growth factor 1; HDL; high density lipoprotein; HOMA-IR; homeostatic model assessment of insulin resistance; HbA1c; glycated hemoglobin; HFD;
Keywords: نوش; Bacterial translocation; Cirrhosis; Hepatitis; Liver diseases; Microbiota; Probiotics; GI; gastrointestinal; BECs; biliary epithelial cells; TLRs; Toll-like receptors; IL; interleukin; TNF; tumor necrosis factor; LPS; lipopolysaccharide; NF-κβ; nuclear
Keywords: نوش; Augmenter of Liver Regeneration; Mouse Model; NASH; ALD; ACACA; acetyl-CoA carboxylase; Adeno-Cre; adenovirus containing Cre recombinase; ALD; alcoholic liver disease; ALR; augmenter of liver regeneration; ASH; alcoholic steatohepatitis; ATP; adenosine tr
Keywords: نوش; NAFLD; nonalcoholic steatohepatitis; NASH; insulin resistance; cryptogenic cirrhosisALT, Alanine Aminotransferase; APO C3, Apolipoprotein C3; ARFI, Acoustic Radiation Forced Impulse; AST, Aspartate Aminotransferase; ATPIII, Adult Treatment Panel III; BMI,
Keywords: نوش; NASH; Prognosis; PRELHIN Study; Prediction; BMI; body mass index; CI; confidence interval; CRN; Clinical Research Network; HCC; hepatocellular cancer; HR; hazard ratio; IQR; interquartile range; NAFLD; nonalcoholic fatty liver disease; NAS; nonalcoholic f
Keywords: نوش; ACS; acyl-coenzyme A synthase; adipoR; adiponectin receptor; ADP; adenosine diphosphate; AP2diph; attenuated P2 diphtheria toxin; AOX; acyl-coenzyme A oxidase; ApoE; apolipoprotein E; ATP; adenosine triphosphate; CBS; cystathionine-β-synthase; CD36; clus
Keywords: نوش; Fibrosis; Cirrhosis; Nonalcoholic Steatohepatitis; Fatty Liver; Natural History; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; FPR; fibrosis progression rate; I2; inconsistency index; NAFL; nonalcoholic fatty liv
Keywords: نوش; ALT; alanine aminotransferase; AMPK; AMP-activated protein kinase; AST; aspartate aminotransferase; CDAA diet; choline-deficient/l-amino acid-defined diet; GLP-2; glucagon-like peptide-2; HFD; high fat diet; IL-1; interleukin 1; IL-6; interleukin 6; Fiaf;
Keywords: نوش; Liver Transplantation; HCC; Cholabgiocarcinoma; Machine Perfusion; Hepatitis C; AASLD; American Association for the Study of Liver Diseases; BAR; balance of risk; D-MELD; donor age à recipient Model of End-Stage Liver Disease; DCC; distal cholangiocarci
Keywords: نوش; AMPK; 5â²-adenosine monophosphate-activated protein kinase; BMI; body mass index; CHB; chronic hepatitis B; CHC; chronic hepatitis C; ChREBP; carbohydrate response element binding protein; Fox; forkhead box protein; HCC; hepatocellular carcinoma; HSCs;
Keywords: نوش; Liver Cirrhosis; Serum Markers; Imaging; ARFI; SWE; TE; Magnetic Resonance Imaging; Liver Stiffness; Elastography; Shear Wave; NAFLD Fibrosis Score; BARD; APRI; aspartate aminotransferase-to-platelet ratio; ARFI; acoustic radiation force impulse; AST/ALT;
Keywords: نوش; Gene Expression; IL8; Immune Regulation; Inflammatory Response; ALT; alanine aminotransferase; AST; aspartate aminotransferase; AT; adipose tissue; ATM; adipose tissue macrophage; AUROC; area under receiver operating characteristic; BMI; body mass index;
Keywords: نوش; Pediatric; Severe Obesity; Microarray; Inflammation; ALT; alanine aminotransferase; BMI; body mass index; FC; fold change; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; Teen-LABS; Teen Longitudinal Assessment of Bariatric Su
Keywords: نوش; CVD; cardiovascular disease; METS; metabolic equivalents; MVPA; moderate-vigorous physical activity; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcohol steatohepatitis; PA; physical activity; VLDL; very low density lipoproteins; WC; waist circu
Keywords: نوش; AOR; adjusted odds ratio; BMI; body mass index; CI; confidence interval; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; OR; odds ratio; Nonalcoholic fatty liver; Children; Ultrasonongraphy; Steatohepatitis; Secondhand smoke;
Keywords: نوش; Mediterranean diet; Inflammatory markers; Transient elastography; Liver biopsy; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BMI; body mass index; BIA; bioelectrical impedance analysis; FFQ; food frequency questionnaire; GGT; gamma-glut
Keywords: نوش; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; ETP; endogenous thrombin potential; PICI; Protac® induced coagulation inhibition; Factor VIII; Protein C; Protac®; Thrombomodulin; Thrombin generation;
Keywords: نوش; Calcium; Cardiovascular diseases; Epidemiology; Imaging; Liver; Obesity; Risk factors; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; VAT; visceral adipose tissue; CAC; coronary artery calcification; AAC; abdominal aortic c
Keywords: نوش; AKT; protein kinase B; ALT; alanine aminotransferase; AST; Aspartate aminotransferase; HDL; high-density lipoprotein; HFD; high-fat diet; iNOS; inducible nitric oxide synthase; IL; interleukin; ipGTT; intraperitoneal glucose tolerance test; ITT; insulin t
Keywords: نوش; NAFLD; NASH; Steatosis; Probiotics; Obesity; Gastrointestinal Tract; Adolescents
Keywords: نوش; NASH; metadoxine; controlled clinical trialALD, alcoholic liver disease; ALT, alanine transaminase; ANCOVA, analysis of covariance; AST, aspartate transaminase; ATP, adenosine triphosphate; GGT, gamma-glutamyl transferase; GSH, glutathione; HOMA-IR, homeo
Keywords: نوش; NAFLD; non-alcoholic fatty liver disease; NAFL; non-alcoholic fatty liver; NASH; non-alcoholic steatohepatitis; CLD; chronic liver disease; NFS; NAFLD Fibrosis Score; BMI; body mass index; ET2DS; Edinburgh Type 2 Diabetes Study; LDR; Lothian Diabetes Regi
Keywords: نوش; ALT; Alanine aminotransferase; AST; Aspartate aminotransferase; BMI; Body mass index; CART; Classification and regression tree; HDL; High-density lipoprotein; HgbA1c; Hemoglobin A1c; HOMA-IR; Homeostatic model assessment of insulin resistance; MRI; Magnet
Keywords: نوش; ADR; adverse drug reaction; Oatp; organic anion transporting polypeptide; SNP; single nucleotide polymorphism; NASH; Non-alcoholic steatohepatitis; NAFLD; Non-alcoholic fatty liver disease; MCD; methionine and choline deficient; AUC; area under the curve;
Keywords: نوش; AHI; Apnea hypopnea index; ALT; Alanine aminotransferase; AST; Aspartate aminotransferase; BMI; Body mass index; HPF; High-power field; NAFLD; Nonalcoholic fatty liver disease; NAS; Nonalcoholic fatty liver disease activity score; NASH; Nonalcoholic steat
Keywords: نوش; α-SMA; alpha-smooth muscle actin; ALT; alanine aminotransferase; DAB; 3,3â²-diaminobenzidine; ECL; enhanced chemiluminescence; GS; glutamine synthase; hMSC; human mesenchymal stem cells; HRP; horse radish peroxidase; LCN2; Lipocalin 2; MCD; methionine-
Keywords: نوش; ALT; alanine aminotransferase; FC; free cholesterol; GREACE; Greek Artorvastatin and Coronary Heart Disease Evaluation; HDL; high-density lipoprotein; HMGCoA; 3-hydroxy-3-methylglutaryl-coenzyme A; LDL; low-density lipoprotein; NAFLD; nonalcoholic fatty
Keywords: نوش; ALT; alanine aminotransferase; ApoAI; apolipoprotein AI resp. ApoAII, ApoCII, ApoCIII; AST; aspartate aminotransferase; CRP; C-reactive protein; DGLA; dihomo-gamma-linolenic acid; FFA; free fatty acid; GGT; gamma glutamyltransferase; IL-6; interleukin-6;
Keywords: نوش; NASH; Histology; Diagnosis; PrognosisAH, alcoholic hepatitis; ALD, alcoholic liver disease; HCC, hepatocellular carcinoma; IL, interleukin; K, keratin; MIR, microRNA; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis
Keywords: نوش; ABCA1; ATP binding cassette transporter A1; Actb; beta-actin; ApoA-I; apolipoprotein A-I; B2m; beta-2 microglobulin; Cyp2E1; cytochrome P450 2E1; FXR; farnesoid X receptor; Gapdh; glyceraldehyde-3-phosphate dehydrogenase; GLUT1; glucose transporter 1; HDL
Keywords: نوش; NASH; Hypotaurine; GC/MS; Metabolome analysis
Keywords: نوش; NAFLD; Non-alcoholic fatty liver disease; NASH; Non-alcoholic steatohepatitis; APAP; acetaminophen; ALI; acute liver injury; ALF; acute liver failure; ALD; alcoholic liver disease; CK18; cytokeratin-18; FasL; Fas Ligand; MMP; matrix metalloproteinase; sFa
Keywords: نوش; BHB; β-hydroxybutyrate; en%; energy percent; g%; gram percent; HF; high fat (42 en%); HP; high protein (35 en%); HPX; high protein (58 en%); LF; low fat (8 en%); LP; low protein (11 en%); mmBCFA; monomethyl branched-chain fatty acid; NAFLD; nonalcoholic